Ajooni Biotech

{
  "main_header": {
    "sid": 1002898,
    "name": "Ajooni Biotech",
    "stock_name": "Ajooni Biotech",
    "full_name": "Ajooni Biotech Ltd",
    "name_url": "stocks-analysis/ajooni-biotech",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.92",
    "chg": 0.08,
    "chgp": "2.08%",
    "dir": 1,
    "prev_price": "3.84",
    "mcapval": "67.52 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "AJOONI",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE820Y01021",
    "curr_date": "Jan 30",
    "curr_time": "",
    "bse_nse_vol": 564373,
    "exc_status": "Active",
    "traded_date": "Jan 30, 2026",
    "traded_date_str": "2026 01 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ajooni-biotech-1002898-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3810959",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AjooniBiotechLt_mojoScore_3810959.png",
        "date": "2026-01-30 10:11:27",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating was revised at the start of the year, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 30 January 2026, providing investors with an up-to-date view of the company’s position."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-by-marketsmojo-3793905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AjooniBiotechLt_mojoScore_3793905.png",
        "date": "2026-01-19 10:10:46",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating was revised at the start of the year, the analysis and financial metrics presented here reflect the stock's current position as of 19 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3784270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AjooniBiotechLt_mojoScore_3784270.png",
        "date": "2026-01-07 10:10:55",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-strong-sell-3769524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AjooniBiotechLt_mojoScore_3769524.png",
        "date": "2025-12-25 15:13:16",
        "description": "Ajooni Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Why is Ajooni Biotech Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ajooni-biotech-ltd-fallingrising-3768835",
        "imagepath": "",
        "date": "2025-12-25 02:12:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock's modest gain on 24 December reflects a short-term positive momentum, with a weekly return of 3.23% surpassing the Sensex's 1.25% over the same period. However, this recent uptick contrasts with the stock's longer-term performance, where it has declined sharply. Year-to-date, Ajooni Biotech has lost 42.47%, while the Sensex has gained 10.56%. Over one year, the stock's return stands at -37.31%, significantly lagging the benchmark's 10.18% rise. This persistent underperformance extends over three and five years, with the stock falling 26.72% and 20.41% respectively, while the Sensex has surged 46.81% and 90.13% in those periods.</p>\n<p><strong>Technical Indicators and Trading Activity</strong></p>\n<p>On the technical front, th..."
      },
      {
        "title": "Ajooni Biotech Sees Revision in Market Assessment Amidst Challenging Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-downgraded-to-strong-sell-amid-declining-mojo-score-and-bearish-technicals-3749765",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AjooniBiotech_mojoScore_3749765.png",
        "date": "2025-12-06 10:10:33",
        "description": "Ajooni Biotech, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trajectory, and technical outlook amid a backdrop of sustained stock price declines."
      },
      {
        "title": "How has been the historical performance of Ajooni Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ajooni-biotech-3718922",
        "imagepath": "",
        "date": "2025-11-20 22:55:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue Growth and Profitability Trends</strong></p>\n<p>Over the seven-year period ending March 2025, Ajooni Biotech's net sales have shown a robust increase, rising from ₹39.72 crores in March 2019 to ₹114.69 crores in March 2025. This represents nearly a threefold growth, with particularly notable jumps between March 2021 and March 2025. The total operating income closely mirrors this trend, indicating that other operating income has been negligible in recent years.</p>\n<p>Operating profit before depreciation and interest (PBDIT) excluding other income has also improved, reaching ₹3.68 crores in March 2025 from ₹0.89 crores in March 2019. When factoring in other income, operating profit rose to ₹5.75 crores in the latest fiscal year. However, operating profit margins have remained relative..."
      },
      {
        "title": "Why is Ajooni Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ajooni-biotech-fallingrising-3716539",
        "imagepath": "",
        "date": "2025-11-19 23:56:08",
        "description": "As of 19-Nov, Ajooni Biotech Ltd's stock price is currently at Rs. 4.67, reflecting a decrease of Rs. 0.27, or 5.47%. The stock has recently hit a new 52-week low of Rs. 4.16 and is underperforming its sector by 5.33%. Additionally, Ajooni Biotech is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock's performance over the past week shows a decline of 6.41%, and it has experienced a significant year-to-date drop of 39.90%, contrasting sharply with the Sensex, which has gained 10.18% during the same period. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 10.86% compared to the 5-day average.\n\nIn the broader market context, Ajooni Biotech's recent performance starkly contrasts with the Sensex's positive movement, which has risen by 0.68% over the past week. This divergence suggests that ..."
      },
      {
        "title": "Ajooni Biotech Q2 FY26: Revenue Growth Masks Margin Pressures",
        "link": "https://www.marketsmojo.com/news/result-analysis/ajooni-biotech-q2-fy26-revenue-growth-masks-margin-pressures-3715392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AjooniBiotech_quaterlyResult_3715392.png",
        "date": "2025-11-14 09:42:15",
        "description": "Ajooni Biotech Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹89.05 crores, reported net profit of ₹0.93 crores for Q2 FY26, marking a 19.23% sequential increase from ₹0.78 crores in Q1 FY26 and a 50.00% year-on-year jump from ₹0.62 crores in Q2 FY25. Despite the profit expansion, the company's stock has struggled significantly, declining 30.23% over the past year whilst the broader Sensex gained 8.53%, resulting in a stark underperformance of 38.76 percentage points. The company's current share price of ₹5.17 reflects persistent concerns about operational efficiency and profitability sustainability."
      }
    ],
    "total": 99,
    "sid": "1002898",
    "stock_news_url": "https://www.marketsmojo.com/news/ajooni-biotech-1002898"
  },
  "announcements": [
    {
      "details": "Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Ajooni Biotech Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": "Ajooni Biotech Limited with respect to announcement dated 14-Oct-2019, that the Board of Directors in their meeting held on October 14, 2019 has considered and approved the resignation of Ms. Kanika Sapra, Company Secretary and Compliance Officer of the Company. On basis of above the Company is required to clarify following: 1. Date of resignation of Ms. Kanika Sapra. The response of the Company is awaited.",
      "source": "NSE",
      "caption": "Ajooni Biotech Limited - Clarification",
      "datetime": "23-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(30 Jan 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ajooni Biotech Ltd has announced <strong>2:10</strong> stock split, ex-date: 07 Oct 22",
          "dt": "2022-10-07",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Ajooni Biotech Ltd has announced <strong>1:9</strong> bonus issue, ex-date: 10 Mar 21",
          "dt": "2021-03-10",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Ajooni Biotech Ltd has announced <strong>1:1</strong> rights issue, ex-date: 07 May 24",
          "dt": "2024-05-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Ajooni Biotech Ltd is Rated Sell

2026-01-30 10:11:27

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating was revised at the start of the year, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 30 January 2026, providing investors with an up-to-date view of the company’s position.

Read full news article

Ajooni Biotech Ltd is Rated Sell by MarketsMOJO

2026-01-19 10:10:46

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating was revised at the start of the year, the analysis and financial metrics presented here reflect the stock's current position as of 19 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Ajooni Biotech Ltd is Rated Sell

2026-01-07 10:10:55

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Ajooni Biotech Ltd is Rated Strong Sell

2025-12-25 15:13:16

Ajooni Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.

Read full news article

Why is Ajooni Biotech Ltd falling/rising?

2025-12-25 02:12:10

Recent Price Movement and Market Context

The stock's modest gain on 24 December reflects a short-term positive momentum, with a weekly return of 3.23% surpassing the Sensex's 1.25% over the same period. However, this recent uptick contrasts with the stock's longer-term performance, where it has declined sharply. Year-to-date, Ajooni Biotech has lost 42.47%, while the Sensex has gained 10.56%. Over one year, the stock's return stands at -37.31%, significantly lagging the benchmark's 10.18% rise. This persistent underperformance extends over three and five years, with the stock falling 26.72% and 20.41% respectively, while the Sensex has surged 46.81% and 90.13% in those periods.

Technical Indicators and Trading Activity

On the technical front, th...

Read full news article

Ajooni Biotech Sees Revision in Market Assessment Amidst Challenging Trends

2025-12-06 10:10:33

Ajooni Biotech, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trajectory, and technical outlook amid a backdrop of sustained stock price declines.

Read full news article

How has been the historical performance of Ajooni Biotech?

2025-11-20 22:55:46

Revenue Growth and Profitability Trends

Over the seven-year period ending March 2025, Ajooni Biotech's net sales have shown a robust increase, rising from ₹39.72 crores in March 2019 to ₹114.69 crores in March 2025. This represents nearly a threefold growth, with particularly notable jumps between March 2021 and March 2025. The total operating income closely mirrors this trend, indicating that other operating income has been negligible in recent years.

Operating profit before depreciation and interest (PBDIT) excluding other income has also improved, reaching ₹3.68 crores in March 2025 from ₹0.89 crores in March 2019. When factoring in other income, operating profit rose to ₹5.75 crores in the latest fiscal year. However, operating profit margins have remained relative...

Read full news article

Why is Ajooni Biotech falling/rising?

2025-11-19 23:56:08

As of 19-Nov, Ajooni Biotech Ltd's stock price is currently at Rs. 4.67, reflecting a decrease of Rs. 0.27, or 5.47%. The stock has recently hit a new 52-week low of Rs. 4.16 and is underperforming its sector by 5.33%. Additionally, Ajooni Biotech is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock's performance over the past week shows a decline of 6.41%, and it has experienced a significant year-to-date drop of 39.90%, contrasting sharply with the Sensex, which has gained 10.18% during the same period. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 10.86% compared to the 5-day average. In the broader market context, Ajooni Biotech's recent performance starkly contrasts with the Sensex's positive movement, which has risen by 0.68% over the past week. This divergence suggests that ...

Read full news article

Ajooni Biotech Q2 FY26: Revenue Growth Masks Margin Pressures

2025-11-14 09:42:15

Ajooni Biotech Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹89.05 crores, reported net profit of ₹0.93 crores for Q2 FY26, marking a 19.23% sequential increase from ₹0.78 crores in Q1 FY26 and a 50.00% year-on-year jump from ₹0.62 crores in Q2 FY25. Despite the profit expansion, the company's stock has struggled significantly, declining 30.23% over the past year whilst the broader Sensex gained 8.53%, resulting in a stark underperformance of 38.76 percentage points. The company's current share price of ₹5.17 reflects persistent concerns about operational efficiency and profitability sustainability.

Read full news article

View All News